- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05882448
Studie van de invloed van intraperitoneale insufflatie van CO2 door laparoscopie op de kortetermijnevolutie van premature baby's met ulceratieve necrotiserende enterocolitis (NECO2)
Studie van de invloed van intraperitoneale insufflatie van koolstofdioxide (CO2) door laparoscopie op de kortetermijnevolutie van te vroeg geboren baby's met ulceratieve necrotiserende enterocolitis
Ulcerative-necrotizing enterocolitis (ECUN) is an infectious and inflammatory disease of the digestive tract, which can lead to intestinal necrosis or perforation.
This severe pathology of the newborn , often premature, requires urgent medical and surgical treatment in 25 to 50% of cases. The morbidity is high, both digestive and neurological. ECUN can lead to complications at short-term (death, intestinal stenosis) and at long-term (neuro-cognitive disorders). The challenge of preserving the neurological development is a major issue. It involves control of inflammation. This inflammation causes neurological lesions and is responsible for a disorder of the long-term neurocognitive development.
At Robert-Debré and Trousseau, the management of newborns with ECUN is focused on the control of this inflammation. A laparoscopy is performed first. The carbon dioxide (CO2) insufflated into the abdomen during a laparoscopy is thought to have an anti-inflammatory effect according to several experimental and clinical studies. A preliminary retrospective study at Robert-Debré showed a decrease in postoperative inflammation (decrease in C reactive protein at Day2 and Day 7 post-op) as well as a decrease in morbimortality (decrease in the rate of stoma and reoperation) in children who had a laparoscopic first operation compared to those who had a laparotomy alone. However, in many hospitals, laparotomy alone is currently the only surgical option.
This preliminary study may demonstrate that laparoscopy decreases early morbidity and mortality in children with ECUN through reduced inflammation, as reflected by postoperative C reactive protein.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
NECO2 is a pilot trial, evaluating the intermediate effectiveness to short/medium term of laparoscopy on the inflammatory reaction of premature newborns with complicated ECUN, requiring surgical treatment.
This is a multicenter randomized controlled trial in single blind, in two parallel arms, in ratio 1:1, of superiority.
This trial compares laparoscopy plus laparotomy versus laparotomy alone.
Children will be randomized into 2 groups:
- Laparoscopy + laparotomy group
- Laparotomy group
The main objective is to evaluate the inflammatory response Day 2 postoperative in preterm infants with ECUN who have undergone surgery.
The main criterion is the evolution of the blood C reactive protein level between Day 0 and Day 2 postoperatively.
The secondary objectives are:To evaluate in premature babies with ECUN who have had a surgical intervention (laparoscopy + laparotomy or laparotomy alone):
A.The postoperative biological inflammatory response at Day 7 B.Post-operative biological inflammatory response from Day 0 to Day 7 C.Post-operative mortality D.Post-operative bowel morbidity E.Post-operative re-intervention rate F.Length of hospital stay G.Post-operative neurological morbidity, medium term (corrected term 41 SA)
- To evaluate the tolerance of laparoscopy :
H.Intraoperative cardiorespiratory I.Loco-regional lesions linked to the insertion of the trocar
Secondary endpoints:
A. C reactive protein blood level at Day 7 B. Blood levels of Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha at Day 1, Day 2, Day 4, Day 7 C. Postoperative death from any cause D. Stoma rate, duration of parenteral nutrition, duration of hemodynamic support, duration of invasive ventilation (High frequency oscillatory ventilation/Synchronized Intermittent Mandatory Ventilation), Post-ECUN intestinal stenosis rate E. Re-intervention (laparotomy) and cause (post-ECUN stenosis, stoma closure) F. Length of hospital stay until return home G. Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at the corrected term of 41 weeks of amenorrhea, H. Oxygen saturation (SaO2), hypercapnia (pCO2) blood pressure (BP), cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively I. Intraoperative clinical monitoring: exploration of adjacent organs. Post-operative clinical monitoring: digestive signs monitoring of wounds until discharge.
Group 1: laparotomy only Group 2: laparotomy and laparoscopy
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Louise MONTALVA, Dr
- Telefoonnummer: +33 1.71.73.89.97
- E-mail: louise.montalva@aphp.fr
Studie Contact Back-up
- Naam: Arnaud BONNARD, Pr
- Telefoonnummer: +33 1 40 03 23 59
- E-mail: arnaud.bonnard@aphp.fr
Studie Locaties
-
-
-
Paris, Frankrijk, 75012
- Werving
- Hôpital Armand Trousseau Service de Chirurgie Pédiatrique et Néonatale
-
Contact:
- MONTALVA Louise, Dr
- Telefoonnummer: +33 +33 1.71.73.89.97
- E-mail: louise.montalva@aphp.fr
-
Paris, Frankrijk
- Werving
- Hôpital Robert Debré Service de Chirurgie Pédiatrique
-
Contact:
- BONNARD Arnaud, Pr
- Telefoonnummer: +33 33 1 40 03 41 21
- E-mail: arnaud.bonnard@aphp.fr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Premature newborn (term of birth: <37 weeks of amenorrhea)
- Diagnosis of ECUN by the surgeon (distension abdominal +/- rectal bleeding +/- green gastric residue, increased biological inflammatory syndrome, + pneumatosis on abdominal radiography)
- Hospitalized and complicated ECUN: presenting either a pneumoperitoneum on abdominal X-ray or a absence of clinical and biological improvement after 48 hours of maximum well-conducted medical treatment (IV antibiotic therapy and digestive rest).
- Hospitalized in the 2 participating centers
- Of which the 2 holders of parental authority have been informed and have signed the consent form
- Having social security coverage (social security or CMU)
Exclusion Criteria:
- Instability contraindicating movement to the operating room or contraindicating CO2 insufflation
- Diagnosis of isolated perforation of the small intestine (radiography:
pneumoperitoneum without pneumatosis)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Laparotomy
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion |
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion |
|
Experimenteel: Laparotomy and laparoscopy
Exploratory and therapeutic laparotomy if necessary preceded by laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes. |
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
C reactive protein blood level
Tijdsspanne: between Day 0 and Day 2 post surgery
|
C reactive protein blood level |
between Day 0 and Day 2 post surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Postoperative biological inflammatory reaction
Tijdsspanne: Day 7 post surgery
|
C reactive protein blood level |
Day 7 post surgery
|
|
Specific post-operative biological inflammatory reaction
Tijdsspanne: Day1, day 2, day 4 and day 7 post surgery
|
Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha blood level |
Day1, day 2, day 4 and day 7 post surgery
|
|
Postoperative mortality
Tijdsspanne: up to 3 months
|
Death due to any postoperative cause |
up to 3 months
|
|
Postoperative intestinal morbidity: stoma rate
Tijdsspanne: up to 3 months
|
Stoma rate |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of parenteral nutrition
Tijdsspanne: up to 3 months
|
Duration of parenteral nutrition |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of hemodynamic support
Tijdsspanne: up to 3 months
|
Duration of hemodynamic support |
up to 3 months
|
|
Postoperative intestinal morbidity: Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation)
Tijdsspanne: up to 3 months
|
Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation) |
up to 3 months
|
|
Postoperative intestinal morbidity: Rate of intestinal stenosis post-ECUN
Tijdsspanne: up to 3 months
|
Rate of intestinal stenosis post-ECUN |
up to 3 months
|
|
Postoperative reoperation rate
Tijdsspanne: up to 3 months
|
Reoperation (laparotomy) and cause (post ECUN stenosis, stoma closure) |
up to 3 months
|
|
Length of hospitalization
Tijdsspanne: up to 3 months
|
Duration of hospitalization until return home |
up to 3 months
|
|
Medium-term postoperative neurological morbidity
Tijdsspanne: up to 3 months
|
Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at term corrected for 41 weeks of amenorrhea |
up to 3 months
|
|
Oxygen saturation (SaO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Tijdsspanne: During Surgery
|
Oxygen saturation (SaO2) |
During Surgery
|
|
Hypercapnia (pCO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Tijdsspanne: During Surgery
|
hypercapnia (pCO2) |
During Surgery
|
|
Blood pressure (BP) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Tijdsspanne: During Surgery
|
blood pressure (systolic and diastolic) |
During Surgery
|
|
Cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) (Tolerance of laparoscopy (Intraoperative cardio-respiratory))
Tijdsspanne: During Surgery
|
cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively |
During Surgery
|
|
Presence of loco-regional lesions related to the insertion of the trocar (Tolerance of laparoscopy)
Tijdsspanne: up to 3 months
|
Presence of loco-regional lesions related to the insertion of the trocar |
up to 3 months
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Vrouwelijke urogenitale ziekten en zwangerschapscomplicaties
- Darmziekten
- Verloskundige arbeid, voortijdig
- Verloskundige arbeidscomplicaties
- Zwangerschap Complicaties
- Ziekten van het spijsverteringsstelsel
- Gastro-intestinale aandoeningen
- Gastro-enteritis
- Enterocolitis
- Voortijdige geboorte
- Enterocolitis, necrotiserend
- Diagnostische technieken en procedures
- Diagnose
- Chirurgische procedures, operatief
- Minimaal invasieve chirurgische procedures
- Diagnostische technieken, chirurgisch
- Endoscopie
- Laparoscopie
- Laparotomie
Andere studie-ID-nummers
- APHP221170
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .